Area of research
Oncology · Pulmonary and Respiratory Medicine
Research interest
Research interests include Cancer Cells and Metastasis, Advanced Breast Cancer Therapies, Breast Cancer Treatment Studies, and HER2/EGFR in Cancer Research.
Effectiveness comparison of palbociclib, ribociclib and abemaciclib in patients with HR+/HER2- aBC: Updated results from the real-world, Italian study PALMARES-2.
414P The complex relationship between circulating tumor cells (CTCs) and brain metastases (BMs) in metastatic breast cancer (mBC): A retrospective pooled analysis
Novel endocrine therapies: What is next in estrogen receptor positive, HER2 negative breast cancer?
Association of tumor-infiltrating lymphocytes with recurrence score in hormone receptor-positive/HER2-negative breast cancer: Analysis of four prospective studies
Multiple Bayesian network meta-analyses to establish therapeutic algorithms for metastatic triple negative breast cancer
New steps on an old path: Novel estrogen receptor inhibitors in breast cancer
Modeling the Prognostic Impact of Circulating Tumor Cells Enumeration in Metastatic Breast Cancer for Clinical Trial Design Simulation
Poly (ADP-ribose) polymerase inhibitors in solid tumours: Systematic review and meta-analysis
Endocrine-Based Treatments in Clinically-Relevant Subgroups of Hormone Receptor-Positive/HER2-Negative Metastatic Breast Cancer: Systematic Review and Meta-Analysis
Overall Survival of CDK4/6-Inhibitor–Based Treatments in Clinically Relevant Subgroups of Metastatic Breast Cancer: Systematic Review and Meta-Analysis
Endocrine treatment versus chemotherapy in postmenopausal women with hormone receptor-positive, HER2-negative, metastatic breast cancer: a systematic review and network meta-analysis
The clinical use of circulating tumor cells (CTCs) enumeration for staging of metastatic breast cancer (MBC): International expert consensus paper
Perspective on Circulating Tumor Cell Clusters: Why It Takes a Village to Metastasize
CDK 4/6 Inhibitors as Single Agent in Advanced Solid Tumors
Nab-paclitaxel for the treatment of triple-negative breast cancer: Rationale, clinical data and future perspectives
Upregulation of ER Signaling as an Adaptive Mechanism of Cell Survival in HER2-Positive Breast Tumors Treated with Anti-HER2 Therapy
Circulating tumor cells as early predictors of metastatic spread in breast cancer patients with limited metastatic dissemination
Bidirectional Crosstalk between the Estrogen Receptor and Human Epidermal Growth Factor Receptor 2 Signaling Pathways in Breast Cancer: Molecular Basis and Clinical Implications